These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23893609)

  • 1. The effects of methamphetamine self-administration on cortical monoaminergic deficits induced by subsequent high-dose methamphetamine administrations.
    McFadden LM; Hanson GR; Fleckenstein AE
    Synapse; 2013 Dec; 67(12):875-81. PubMed ID: 23893609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.
    McFadden LM; Hunt MM; Vieira-Brock PL; Muehle J; Nielsen SM; Allen SC; Hanson GR; Fleckenstein AE
    Drug Alcohol Depend; 2012 Nov; 126(1-2):87-94. PubMed ID: 22647900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor.
    McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1315-20. PubMed ID: 24650575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.
    Krasnova IN; Justinova Z; Ladenheim B; Jayanthi S; McCoy MT; Barnes C; Warner JE; Goldberg SR; Cadet JL
    PLoS One; 2010 Jan; 5(1):e8790. PubMed ID: 20098750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine self-administration acutely decreases monoaminergic transporter function.
    McFadden LM; Stout KA; Vieira-Brock PL; Allen SC; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    Synapse; 2012 Mar; 66(3):240-5. PubMed ID: 22120988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.
    Kuczenski R; Segal DS; Melega WP; Lacan G; McCunney SJ
    Neuropsychopharmacology; 2009 Oct; 34(11):2430-41. PubMed ID: 19571794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of methamphetamine on Na(+)/Cl(-)-dependent transporters.
    Haughey HM; Brown JM; Wilkins DG; Hanson GR; Fleckenstein AE
    Brain Res; 2000 Apr; 863(1-2):59-65. PubMed ID: 10773193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.
    Schweppe CA; Burzynski C; Jayanthi S; Ladenheim B; Cadet JL; Gardner EL; Xi ZX; van Praag H; Newman AH; Keck TM
    Psychopharmacology (Berl); 2020 Jul; 237(7):1989-2005. PubMed ID: 32388619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake.
    Rau KS; Birdsall E; Volz TJ; Riordan JA; Baucum AJ; Adair BP; Bitter R; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):676-82. PubMed ID: 16687477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
    J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine-induced changes in the object recognition memory circuit.
    Reichel CM; Ramsey LA; Schwendt M; McGinty JF; See RE
    Neuropharmacology; 2012 Feb; 62(2):1119-26. PubMed ID: 22115899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo.
    Sabol KE; Roach JT; Broom SL; Ferreira C; Preau MM
    Brain Res; 2001 Feb; 892(1):122-9. PubMed ID: 11172757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extinction-dependent alterations in corticostriatal mGluR2/3 and mGluR7 receptors following chronic methamphetamine self-administration in rats.
    Schwendt M; Reichel CM; See RE
    PLoS One; 2012; 7(3):e34299. PubMed ID: 22479593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine preconditioning: differential protective effects on monoaminergic systems in the rat brain.
    Cadet JL; Krasnova IN; Ladenheim B; Cai NS; McCoy MT; Atianjoh FE
    Neurotox Res; 2009 Apr; 15(3):252-9. PubMed ID: 19384598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat.
    Kuczenski R; Everall IP; Crews L; Adame A; Grant I; Masliah E
    Exp Neurol; 2007 Sep; 207(1):42-51. PubMed ID: 17603040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal methamphetamine attenuates serotonin mediated renin secretion in male and female rat progeny: evidence for selective long-term dysfunction of serotonin pathways in brain.
    Cabrera TM; Levy AD; Li Q; van de Kar LD; Battaglia G
    Synapse; 1993 Nov; 15(3):198-208. PubMed ID: 8278897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity.
    Guilarte TR; Nihei MK; McGlothan JL; Howard AS
    Neuroscience; 2003; 122(2):499-513. PubMed ID: 14614914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.